Routine initial ownership filing for a new finance officer. No trading activity or material change to the company's financial position. Monitor for any subsequent Form 4 filings that may indicate insider transactions.
MIST drugs
MIST drug pipeline →Price Chart
How similar events traded
Executive Summary
Anthony J. Krick filed a Form 3 initial statement of beneficial ownership upon becoming Vice President, Finance of Milestone Pharmaceuticals. The filing discloses a grant of 100,000 employee stock options with a strike price of $1.32, vesting over four years. This is a routine insider filing with no material financial impact.
Key Facts
- Anthony J. Krick appointed Vice President, Finance
- Form 3 filed on 2026-11-19, reporting period 2026-11-10
- Grant of 100,000 employee stock options at $1.32 strike price
- Options vest 1/4 on May 7, 2027, then 1/36 monthly
- Options expire July 1, 2036
Financial Impact
100,000 options at $1.32 strike, standard equity grant for a new officer
Risk Factors
- No material risks identified from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001932659-26-000004 |
| Document: 0001932659-26-000004-index-headers.html | 0001932659-26-000004 |
| Document: 0001932659-26-000004-index.html | 0001932659-26-000004 |
| Document: 0001932659-26-000004.txt | 0001932659-26-000004 |
Track record
13 reports on MIST
5 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +50.00% at T+20 after the Mar 20, 2026 report. 6 of 7 went positive at some point.
Filters
- Nov 20, 20261d ago SC 13G/A Neutral 4/10 Entry $0.3752 Now $0.3710 −1.12% settles Nov 30
- Nov 19, 20262d ago 3 Neutral 2/10 Viewing Entry $0.4130 Now $0.3710 −10.17% settles Nov 30
- Nov 13, 20268d ago 8-K Neutral 5/10 Entry $0.5200 to $0.3711 Now $0.3710 −28.65% ▼ −28.63% −20.08% vs SPY
- Oct 28, 202624d ago 8-K Bearish 7/10 Entry $0.7896 to $0.6925 Now $0.3710 +53.01% ▲ +12.30% +7.57% vs SPY
- Sep 3, 202611w ago 8-K Bullish 6/10 Entry $1.20 to $0.9494 Now $0.3710 −69.08% ▼ −20.88% −19.67% vs SPY
- Aug 21, 202613w ago Press Release Bullish 7/10 Entry $1.06 to $1.16 Now $0.3710 −64.83% ▲ +9.95% +9.48% vs SPY
- Aug 12, 202614w ago 8-K Bearish 6/10 Entry $1.13 to $1.08 Now $0.3710 +67.02% ▲ +4.00% +3.56% vs SPY
- May 26, 202625w ago EFFECT Bearish 6/10 Entry $1.40 to $1.32 Now $0.3710 +73.50% ▲ +5.71% +6.93% vs SPY
- May 13, 202627w ago S-3 Bearish 6/10 Entry $1.63 to $1.52 Now $0.3710 +77.24% ▲ +6.75% +6.03% vs SPY
- May 13, 202627w ago 8-K Neutral 5/10 No price data
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers